Jean M De Vry is a notable inventor based in Roesrath, Germany. He has made significant contributions to the field of psychopharmacology, holding a total of 7 patents. His work focuses on innovative methods for treating psychosis, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Among his latest patents is a method of treating psychosis using azaheterocyclylmethyl. This method involves administering to a patient an azaheterocyclylmethyl-chroman of a specific formula, where E represents an azaheterocyclyl group. The patent outlines various substituents, including hydrogen, hydroxyl, halogen, or phenyl, and discusses the potential for optically isomeric forms or salts of the compound. Another significant patent involves azaheterocyclylmethyl-chromans, further emphasizing his innovative approach to psychotropic treatments.

Career Highlights

Jean M De Vry has had a distinguished career, primarily working with Bayer Aktiengesellschaft. His research and inventions have contributed to the development of new therapeutic options for patients suffering from psychosis. His dedication to improving mental health treatment is evident in his patent portfolio.

Collaborations

Throughout his career, Jean has collaborated with esteemed colleagues such as Hans-Georg Heine and Rudolf Schohe-Loop. These partnerships have likely enhanced the quality and impact of his research, leading to groundbreaking advancements in the field.

Conclusion

Jean M De Vry's contributions to the field of psychopharmacology through his innovative patents demonstrate his commitment to improving mental health treatment. His work continues to influence the development of new therapies for psychosis, marking him as a significant figure in the realm of medical inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com